Beauty treatments, medical procedures and personalisation are blending together, with China at the forefront of these key trends.

Dominique Mégret has exclusively revealed to Global Venturing that the unit closed its fourth main fund in July, with 75% of the capital coming from external limited partners.

The Deutsche Telekom spinoff’s Growth Equity III Fund has completed a $300m first close backed by its former parent company as well as SoftBank.

Teri Willey, whose long list of accomplishments includes founding Cambridge Enterprise, will step down in November this year to focus on other projects.

Sean Fielding has worked for University of Exeter for nearly three decades, during which time his board memberships included ATTP, SETsquared and PraxisAuril.

Job moves in the investment arms of telecoms companies over the past year, many of them involving rotation at SoftBank.

Pfizer Ventures has hired Irena Melnikova, formerly CFO of Umoja Biopharma and MD of SVB Leerink, as an executive director.

Danilo Gaspar has been hired by the Brazilian medical education and digital health tool provider as head of corporate venture capital.

Masaji Matsuoka has left Mistui & Co after more than 12 years and joined Magenta Venture Partners as managing general director.

David Clouse, a GCV Emerging Leader this year while at BP Ventures, will lead EIC Rose Rock, a $50m fund backed by Devon Energy, Onoek and Williams.